{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Medi Caps Ltd Stock Falls to 52-Week Low of Rs.21.02 Amidst Continued Financial Struggles
Medi Caps Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a new 52-week low of Rs.21.02 today, marking a significant decline in its stock price amid ongoing financial difficulties and subdued operational performance.
Medi Caps Ltd Stock Falls to 52-Week Low of Rs.21.56 Amidst Continued Weakness
Medi Caps Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a fresh 52-week low of Rs.21.56 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and benchmark indices, reflecting ongoing financial pressures and subdued market sentiment.
Medi Caps Ltd Falls 8.84%: Four Key Factors Driving the Steep Decline
Medi Caps Ltd’s stock declined sharply by 8.84% over the week ending 13 Feb 2026, closing at Rs.22.18 from Rs.24.33, significantly underperforming the Sensex which fell only 0.54% during the same period. The stock hit successive 52-week lows amid deteriorating financial results, weak profitability, and sustained bearish momentum, contrasting with the broader market’s relative resilience.
Medi Caps Ltd Stock Falls to 52-Week Low of Rs.22 Amidst Continued Downtrend
Medi Caps Ltd, a company operating in the Pharmaceuticals & Biotechnology sector, has witnessed its stock price decline to a fresh 52-week low of Rs.22 today, marking a significant downturn amid a broader market environment that remains mixed. This new low reflects ongoing pressures on the company’s financial performance and market valuation.
Are Medi Caps Ltd latest results good or bad?
Medi Caps Ltd's latest results are concerning, showing a 56.61% year-on-year decline in net sales and a net loss of ₹0.77 crores, indicating significant operational challenges despite a sequential revenue increase. The company's financial health is under stress, necessitating urgent action to improve performance and regain investor confidence.
Medi Caps Ltd Stock Falls to 52-Week Low of Rs.22.99 Amidst Continued Weak Performance
Medi Caps Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a fresh 52-week low of Rs.22.99 today, marking a significant decline in its stock price amid ongoing financial pressures and subdued market performance.
Are Medi Caps Ltd latest results good or bad?
Medi Caps Ltd's latest Q2 FY26 results are poor, showing a net loss of ₹1.82 crores and a 75.63% decline in revenue year-on-year, indicating severe operational challenges and inefficiencies. The company faces significant structural issues, with high employee costs and a negative five-year sales growth rate.
Medi Caps Q3 FY26: Losses Deepen as Revenue Struggles Continue
Medi Caps Ltd., one of India's established manufacturers of empty hard gelatine capsules, posted a net loss of ₹0.77 crores in Q3 FY26, marking its third consecutive quarter of losses. The Madhya Pradesh-based pharmaceutical company, with a market capitalisation of ₹31.00 crores, continues to face severe operational headwinds as revenue declined 56.61% year-on-year to ₹4.30 crores during the quarter ended December 2025.
Medi Caps Ltd Stock Falls to 52-Week Low of Rs.24 Amidst Continued Weakness
Medi Caps Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.24 today, marking a significant decline in its stock price amid ongoing financial headwinds and sector underperformance.
Medi Caps Ltd is Rated Strong Sell
Medi Caps Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 February 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 February 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Medi Caps Ltd Stock Falls to 52-Week Low of Rs.24.16 Amidst Continued Downtrend
Medi Caps Ltd, a player in the Pharmaceuticals & Biotechnology sector, has recorded a fresh 52-week low of Rs.24.16 on 6 Feb 2026, marking a significant decline amid a sustained downward trend. The stock has now fallen for three consecutive sessions, shedding 4.77% over this period, reflecting ongoing pressures on its market valuation.
Medi Caps Ltd Stock Falls to 52-Week Low Amidst Continued Weak Performance
Medi Caps Ltd, a player in the Pharmaceuticals & Biotechnology sector, has recently touched a new 52-week low, closing just 1.96% above its lowest price of Rs 24.51. This marks a significant milestone in the stock’s ongoing decline, reflecting persistent pressures on the company’s financial and market performance.
Medi Caps Ltd Stock Falls to 52-Week Low of Rs.24.51 Amidst Weak Financial Metrics
Medi Caps Ltd, a player in the Pharmaceuticals & Biotechnology sector, has recorded a new 52-week low of Rs.24.51 today, marking a significant decline in its stock price amid ongoing financial pressures and subdued market performance.
Medi Caps Ltd Falls to 52-Week Low Amidst Continued Financial Struggles
Medi Caps Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a fresh 52-week low of Rs.25.05 today, marking a significant decline in its stock price amid ongoing financial headwinds and sustained underperformance relative to market benchmarks.
Medi Caps Ltd Stock Falls to 52-Week Low of Rs.25.7 Amidst Continued Downtrend
Medi Caps Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.25.7 today, marking a significant decline amid a sustained negative trend. The stock has underperformed its sector and broader market indices, reflecting ongoing financial and operational pressures.
Medi Caps Ltd Stock Falls to 52-Week Low of Rs.26.55 Amidst Weak Financial Metrics
Medi Caps Ltd, a player in the Pharmaceuticals & Biotechnology sector, has recorded a fresh 52-week low of Rs.26.55 today, marking a significant milestone in its ongoing price decline. The stock has been under pressure for several sessions, reflecting a challenging phase for the company amid subdued financial performance and market conditions.
Medi Caps Ltd Falls to 52-Week Low Amidst Continued Financial Struggles
Medi Caps Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a fresh 52-week low of Rs.27.51 today, marking a significant decline in its stock price amid ongoing financial headwinds and subdued market performance.
Medi Caps Ltd Stock Falls to 52-Week Low of Rs.27.55 Amidst Continued Underperformance
Medi Caps Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a fresh 52-week low of Rs.27.55 today, marking a significant decline in its stock price amid ongoing financial headwinds and sectoral pressures.
Medi Caps Ltd is Rated Strong Sell
Medi Caps Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 February 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 15 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
